Understanding Ozempic: How Much is Prescribed for Weight Loss?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has become a cornerstone of prescription weight loss therapy since its approval for chronic weight management. The medication works by slowing stomach emptying and signaling satiety to the brain, helping patients reduce calorie intake naturally. Understanding how dosing progresses is essential for setting realistic expectations about your weight loss journey.

How Semaglutide Dosing Starts and Progresses

Most semaglutide weight loss protocols begin with a starting dose of 0.25 mg once weekly, which is considered a sub-therapeutic amount designed to minimize gastrointestinal side effects while your body adjusts to the medication. After one week at this dose, your prescriber typically increases to 0.5 mg weekly. This measured ramp-up continues over four weeks, reaching a maintenance dose of 1.0 mg per week for most patients seeking weight loss benefits. The gradual titration approach allows your digestive system to adapt and helps you identify your personal tolerance threshold.

Beyond the standard 1.0 mg weekly dose, some patients benefit from increases to 1.7 mg or 2.4 mg weekly, depending on their response and any side effects experienced. Your PlexusDx prescriber reviews your progress, appetite suppression level, and gastrointestinal tolerance at each step to determine whether dose escalation is appropriate. This individualized approach ensures you receive the minimum effective dose rather than an unnecessarily high amount.

Why Semaglutide Dosing Follows a Gradual Titration Schedule

The body needs time to adapt to GLP-1 receptor activation, particularly in the gastrointestinal tract where nausea and vomiting are most common during early treatment. Jumping to higher doses too quickly can overwhelm your system and cause adverse effects that discourage medication adherence. The four-week titration phase, moving from 0.25 mg to 1.0 mg, represents a clinical compromise between efficacy and tolerability that clinical trials have shown to work well for most patients.

Research on semaglutide for weight loss demonstrates that patients following the gradual dosing schedule experience more stable appetite suppression and better long-term weight loss outcomes than those attempting faster escalation. Your PlexusDx provider uses your weekly feedback—appetite level, side effect severity, and early weight loss trends—to decide whether you're ready to advance or should remain at your current dose for an additional week.

Average Weight Loss Results at Different Semaglutide Doses

Clinical trial data shows that at 1.0 mg weekly, most patients achieve weight loss of 6–8% of their starting body weight over 16 weeks, with continued loss through six months of treatment. Patients who reach the 2.4 mg dose typically see cumulative weight loss ranging from 12–15% over one year, though individual results vary significantly based on diet, exercise, genetics, and baseline metabolic health. Weight loss typically plateaus after 12–18 months of consistent semaglutide use, which is when your prescriber may discuss whether to continue, adjust, or eventually discontinue the medication.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Dosing and Your PlexusDx Treatment Plan

PlexusDx compounded semaglutide injection is manufactured by licensed 503A compounding pharmacies and serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Your monthly investment is $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of whether you're taking 0.25 mg or 2.4 mg weekly—PlexusDx's pricing model ensures that dose adjustments never increase your cost. This flat-rate structure removes a common barrier to optimal dosing: patients no longer face financial pressure to skip dose escalations when clinically indicated.

When you begin PlexusDx semaglutide treatment, your dedicated prescriber creates a personalized titration schedule aligned with your weight loss goals, side effect tolerance, and health history. Monthly follow-up consultations allow real-time dose adjustments, ensuring you advance to higher doses only when appropriate and never remain under-dosed due to cost concerns. HSA and FSA funds are eligible for PlexusDx semaglutide, making personalized weight loss therapy more accessible.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly. After one week, most patients increase to 0.5 mg weekly, then progress to 1.0 mg over four weeks total. PlexusDx providers follow this evidence-based titration schedule and adjust based on your individual tolerance and weight loss response.

How long does it take to reach the full 2.4 mg semaglutide dose?

Reaching the maximum 2.4 mg dose typically takes 16–20 weeks if you escalate by 0.25–0.5 mg weekly and tolerate each step well. Most patients find their optimal dose between 1.0 and 1.7 mg and do not require the full 2.4 mg amount. Your PlexusDx prescriber will pause increases if you're achieving excellent results or experiencing unacceptable side effects at a lower dose.

Does PlexusDx charge more if I increase my semaglutide dose?

No. PlexusDx's flat-rate pricing model means compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) regardless of your dose—whether 0.25 mg or 2.4 mg weekly. Your dose may need to go up. Your price won't. This pricing transparency encourages prescribers to adjust your dose for optimal efficacy without patients worrying about cost escalation.

What side effects should I expect during semaglutide dose escalation?

Nausea, vomiting, diarrhea, and constipation are most common during the first 1–2 weeks at each new dose level, typically resolving as your body adapts. Staying hydrated, eating small frequent meals, and avoiding high-fat foods can minimize gastrointestinal discomfort. If side effects persist or worsen, contact your PlexusDx provider to discuss dose delay or dietary adjustments rather than discontinuing therapy.

How does the Precision Peptide Genetic Test help determine my semaglutide dose?

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways including GLP-1 receptor sensitivity (GLP1R rs6923761) and appetite regulation genes (MC4R, FTO variants). Knowing your genetic predisposition helps your prescriber anticipate whether you'll respond optimally to standard doses or may benefit from earlier escalation to higher amounts, personalizing your titration schedule from day one.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.